These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15649892)

  • 21. Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells.
    Nasrallah R; Clark J; Corinaldi J; Paris G; Miura P; Jasmin BJ; Hébert RL
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1105-12. PubMed ID: 20164153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis.
    Liang SH; Zhang W; McGrath BC; Zhang P; Cavener DR
    Biochem J; 2006 Jan; 393(Pt 1):201-9. PubMed ID: 16124869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
    Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2 eIF2alpha kinase (GCN2), and global translational shutoff.
    Acharya P; Engel JC; Correia MA
    Mol Pharmacol; 2009 Sep; 76(3):503-15. PubMed ID: 19520899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
    Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
    Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells.
    Cheng HC; Ho TC; Chen SL; Lai HY; Hong KF; Tsao YP
    Mol Vis; 2008 Jan; 14():95-104. PubMed ID: 18253093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition.
    Cho DH; Choi YJ; Jo SA; Ryou J; Kim JY; Chung J; Jo I
    Am J Physiol Cell Physiol; 2006 Aug; 291(2):C317-26. PubMed ID: 16825603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma.
    Chana RS; Brunskill NJ
    Am J Nephrol; 2006; 26(1):67-74. PubMed ID: 16508249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.
    Kwon CH; Yoon CS; Kim YK
    Toxicology; 2008 Feb; 244(1):13-24. PubMed ID: 18082925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism.
    Pandey P; Avraham S; Kumar S; Nakazawa A; Place A; Ghanem L; Rana A; Kumar V; Majumder PK; Avraham H; Davis RJ; Kharbanda S
    J Biol Chem; 1999 Apr; 274(15):10140-4. PubMed ID: 10187797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metastasis suppressor, NDRG1, differentially modulates the endoplasmic reticulum stress response.
    Merlot AM; Porter GM; Sahni S; Lim EG; Peres P; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2094-2110. PubMed ID: 30981813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.
    Wakino S; Kintscher U; Liu Z; Kim S; Yin F; Ohba M; Kuroki T; Schönthal AH; Hsueh WA; Law RE
    J Biol Chem; 2001 Dec; 276(50):47650-7. PubMed ID: 11598137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The double-stranded RNA-activated protein kinase PKR is dispensable for regulation of translation initiation in response to either calcium mobilization from the endoplasmic reticulum or essential amino acid starvation.
    Kimball SR; Clemens MJ; Tilleray VJ; Wek RC; Horetsky RL; Jefferson LS
    Biochem Biophys Res Commun; 2001 Jan; 280(1):293-300. PubMed ID: 11162513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells.
    Lee YJ; Suh HN; Han HJ
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1405-16. PubMed ID: 19211687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells.
    Koch A; Völzke A; Puff B; Blankenbach K; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1634-43. PubMed ID: 23906789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α).
    Singh S; Simpson RL; Bennett RG
    J Biol Chem; 2015 Jan; 290(2):950-9. PubMed ID: 25389293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
    Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
    Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    Endocrinology; 2009 Feb; 150(2):862-70. PubMed ID: 19147680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.